Kardiale Schädigungen bei arterieller Hypertonie

  • S. Scheler
  • W. Motz
Conference paper

Zusammenfassung

Neben Niere, Gehirn und peripherem Gefäßsystem ist das Herz das Hauptzielorgan der arteriellen Hypertonie. Vor Verbreitung der antihypertensiven Therapie war die arterielle Hypertonie die Hauptursache von Herzinsuffizienz und Myokardinfarkt. Auch heute noch ist das Risiko, herzinsuffizient zu werden und einen Herzinfarkt zu erleiden, für einen antihypertensiv behandelten Hypertoniker größer als für einen Normotoniker.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. 1.
    Brilla CG, Janicki JS, Weber KT (1991) Cardioreparative effects of lisinopril in rats with genetic hypertension and left ventricular hypertrophy. Circulation 83: 1771–1779PubMedGoogle Scholar
  2. 2.
    Brush JE, Cannon RO, Schenke WH, Bonow HO, Leon MB, Maron BJ, Epstein SE (1988) Angina due to coronary microvascular disease in hypertensive patients without left ventricular hypertrophy. New Engl J Med 319: 1302PubMedCrossRefGoogle Scholar
  3. 3.
    Cannon RO, Watson RM, Rosing DR, Epstein SE (1989) Angina caused by reduced vasodilator reserve of the small coronary arteries. J Amer Coll Cardiol 1: 1359–1373CrossRefGoogle Scholar
  4. 4.
    Caulfield JB, Borg TK (1979) The collagen network of the heart. Invest 40: 364–372Google Scholar
  5. 5.
    Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJL (1994) Linkage of the Angiotensinogen gene to essential hypertension. N Engl J Med 330 (23): 1629–1633PubMedCrossRefGoogle Scholar
  6. 6.
    Dahlmann S (1995) Klinik and Diagnostik der hypertensiven mikrovaskulären Herzkrankheit: Untersuchung an 187 Patienten. Diss H-Heine-Universität DüsseldorfGoogle Scholar
  7. 7.
    Dzau VJ (1993) Local expression and pathophysiological role of renin-angiotensin in the blood vessels and heart. In: Grobecker H, Heusch G, Strauer BE (Eds) Angiotensin and the Heart, Springer, Berlin Heidelberg New York: 1–14CrossRefGoogle Scholar
  8. 8.
    Folkow B (1982) Physiological aspects of primary hypertension. Physiol Rev 62: 347–367PubMedGoogle Scholar
  9. 9.
    Haller H (1997) Risk factors for cardiovascular disease and the endothelium. In: Born GVR, Schwartz C (Eds) Vascular Endothelium: Physiology, Pathology, and Therapeutic Oportunities. Stuttgart, Schattauer: 273–286Google Scholar
  10. 10.
    Hata A (1995) Role of angiotensinogen in the genetics of essential hypertension. Life Sciences 57 (26): 2385–2395PubMedCrossRefGoogle Scholar
  11. 11.
    Lindpainter K, Ganten D (1991) The cardiac renin-angiotensin system. Circulat Res 68: 905–920Google Scholar
  12. 12.
    Mclenachan JM, Henderson E, Morris K, Dragie HJ (1987) Ventricular arrhythmias in patients with hypertensive left ventricular hypertrophy. N Angl J Med 317: 787–792CrossRefGoogle Scholar
  13. 13.
    Messerli FH, Ventura HO, Elizardi DJ, Dunn FG, Frohlich ED (1984) Hypertension and sudden death; increased ventricular ectopic activity in left ventricular hypertrophy. Am J Med 77: 18–22PubMedCrossRefGoogle Scholar
  14. 14.
    Motz W, Vogt M, Rabenau O, Scheler S, Lückhoff A, Strauer BE (1991) Evidence of endothelial dysfunction in coronary resistence vessels in patients with angina pectoris and normal coronary angiograms. Amer J Cardiol 68: 996–1003PubMedCrossRefGoogle Scholar
  15. 15.
    Motz W, Vogt M, Strauer BE (1993) Coronary microcirculation in hypertensive heart disease: functional significance and therapeutic implications. Clin Investig 71: 542–545CrossRefGoogle Scholar
  16. 16.
    Motz W, Strauer BE (1994) Chest pain and angiographically normal coronary arteries in patients with systemic hypertension and left ventricular hypertrophy: mechanism. Kaski JC (Ed) Angina pectoris with normal coronary arteries: Syndrome X. Boston Kluweer Academic PublishersGoogle Scholar
  17. 17.
    Motz W, Strauer BE (1996) Improvement of coronary flow reserve after long-term therapy with enalapril. Hypertension 27: 1031–1038PubMedGoogle Scholar
  18. 18.
    Nava E, Löscher TF (1995) Endothelium-derived vasoactive factors in hypertension: nitric oxide and endothelin. Journal of Hypertension 13: S39–S48PubMedCrossRefGoogle Scholar
  19. 19.
    Opherk D, Mall G, Zebe H, Schwarz F, Weihe H, Manthey J, Kühler W (1984) Reduction of coronary reserve. A mechanism for angina pectoris in patients with arterial hypertension and normal coronary arteries. Circulation 69: 1–7PubMedCrossRefGoogle Scholar
  20. 20.
    Rees DD, Palmer RMJ, Moncada S (1989) Role of endotheliumderived nitric oxide in the regulation of blood pressure. Proc nat Acad Sci (Wash) 86: 3375–3378CrossRefGoogle Scholar
  21. 21.
    Schunkert H, Dzau VJ, Tang SS, Hirsch AT, Apstein CS, Lorell BH (1990) Increased rat cardiac angiotension converting enzyme activity and mRNA expression in pressure overload left ventricular hypertrophy. J Clin Invest 86: 1913–1920PubMedCrossRefGoogle Scholar
  22. 22.
    Schunkert H, Riegger AJG (1992) Molekularbiologie der adaptiven Myokardhypertrophie. Dtsch Med Wschr 117: 1406–1412PubMedCrossRefGoogle Scholar
  23. 23.
    Schwartzkopff B, Motz W, Frenzel, Vogt M, Knauer S, Strauer BE (1993) Structural and functional alterations of the intramyocardial coronary arterioles in patients with arterial hypertension. Circulation 88: 993–1003PubMedGoogle Scholar
  24. 24.
    Strauer BE (1979) Ventricular function and coronary hemodynamics in hypertensive heart disease. Amer J Cardiol 44: 999–1006PubMedCrossRefGoogle Scholar
  25. 25.
    Tauchert M, Kochsiek K, Heiss HW, Strauer BE, Kettler D, Reploh D, Rau G, Bretschneider HJ (1972) Measurements of coronary blood flow in man by the argon method. In: Maseri H (Ed) Myocardial Blood Flow ( Minerva Medica: Torino ): 139–143Google Scholar
  26. 26.
    Treasure CB, Klein JL, Vita JA, Manoukian StV, Renvick GH, Selwyn AP, Ganz P, Alexander RW (1993) Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 87: 86–93PubMedGoogle Scholar
  27. 27.
    Vita JA, Treasure CB, Nabel EG, McLenacham JM, Fish RD, Yeung AC, Vekshtein V, Selwyn AP, Ganz P (1990) Coronary vasomotive response to acetylcholine relates to risk factors for coronary artery disease. Circulation 81: 495–497CrossRefGoogle Scholar
  28. 28.
    Vogt M, Scheler S, Motz W, Strauer BE (1990) Ventrikuläre Herzrhythmusstörungen bei Hypertonikern. Z Kardiol 79: 35Google Scholar
  29. 29.
    Weber KT, Anversa P, Armstrong PW, Brifia CG, Burnett jr JC, Crickshank JM, Devereux R, Giles TD, Korsgaard N, Leier CV, Mendelsohn FAO, Motz W, Mulvany MJ, Strauer BE (1992) Remodeling and reparation of the cardiovascular system. J Amer Coll Cardiol 20: 3–16CrossRefGoogle Scholar
  30. 30.
    Weber KT, Brilla CG (1991) Pathological hypertrophy and the cardiac interstitium. Fibrosis and the reninangiotensin-aldosterone system. Circulation 83: 1849–1865PubMedGoogle Scholar
  31. 31.
    Weber KT, Janicki JS, Pick R, Abrahams C, Shrott SG, Bashey R, Chen RM (1987) Collagen in the hypertrophied, pressureoverloaded myocardium. Circulation 75: 1–40Google Scholar
  32. 32.
    Wilson PWF (1994) Established risk factors and coronary artery disease: The Framingam Study. Am J Hypertens 7: 7SGoogle Scholar
  33. 33.
    Zeiher AM, Drexler H, Wollschlager H, Just H (1991) Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83: 391–401PubMedGoogle Scholar
  34. 34.
    Zeiher AM, Schachlinger V, Hohnloser SH, Saubier B, Hust H (1994) Coronary artherosclerotic wall thickening and vascular reactivity in humans. Elevated high-density lipoprotein levels ameliorate abnormal vasoconstriction in early atherosclerosis. Circulation 89 (6): 2525–2532PubMedGoogle Scholar

Copyright information

© Dr. Dietrich Steinkopff Verlag GmbH & Co. KG, Darmstadt 1999

Authors and Affiliations

  • S. Scheler
    • 1
  • W. Motz
    • 1
    • 2
  1. 1.Herz- und Diabeteszentrum Mecklenburg-VorpommernKlinikum KarlsburgKarlsburgDeutschland
  2. 2.Herz- und Diabeteszentrum Mecklenburg-VorpommernKlinikum KarlsburgGreifswaldDeutschland

Personalised recommendations